S Duty
Overview
Explore the profile of S Duty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hadjivassiliou M, Martindale J, Shanmugarajah P, Grunewald R, Sarrigiannis P, Beauchamp N, et al.
J Neurol Neurosurg Psychiatry
. 2016 Dec;
88(4):301-309.
PMID: 27965395
Background: Cerebellar ataxias are the result of diverse disease processes that can be genetic or acquired. Establishing a diagnosis requires a methodical approach with expert clinical evaluation and investigations. We...
2.
Broadstock M, Austin P, Betts M, Duty S
Br J Pharmacol
. 2011 Jun;
165(4b):1034-45.
PMID: 21627638
Background And Purpose: Increased firing of the glutamatergic pathway between the subthalamic nucleus and substantia nigra pars reticulata (SNpr) contributes to the abnormal firing of motor circuits and subsequent motor...
3.
Austin P, Betts M, Broadstock M, ONeill M, Mitchell S, Duty S
Br J Pharmacol
. 2010 Jul;
160(7):1741-53.
PMID: 20649576
Background And Purpose: Increased glutamatergic innervation of the substantia nigra pars reticulata (SNpr) and pars compacta (SNpc) may contribute to the motor deficits and neurodegeneration, respectively, in Parkinson's disease (PD)....
4.
Hauser R, Meeker J, Singh N, Silva M, Ryan L, Duty S, et al.
Hum Reprod
. 2006 Nov;
22(3):688-95.
PMID: 17090632
Background: The ubiquitous use of phthalate esters in plastics, personal care products and food packaging materials results in widespread general population exposure. In this report, we extend our preliminary study...
5.
Visanji N, ONeill M, Duty S
Neuropharmacology
. 2006 Jul;
51(3):506-16.
PMID: 16814329
Although previous studies suggest nicotine protects against a 6-hydroxydopamine (6-OHDA)-induced lesion of the nigrostriatal tract in rats, it is not known whether functional motor recovery occurs or which nicotinic acetylcholine...
6.
Visanji N, Mitchell S, ONeill M, Duty S
Neuropharmacology
. 2005 Sep;
50(1):36-46.
PMID: 16153666
Whilst local intrastriatal infusion of nicotine consistently elicits striatal dopamine release, systemic administration often fails to do so. Since chronic nicotine administration is known to result in desensitisation-induced upregulation of...
7.
Johnston T, Duty S
Neuroscience
. 2003 Aug;
120(4):1027-35.
PMID: 12927208
Loss of striatal dopaminergic innervation in Parkinson's disease (PD) is accompanied by widespread alterations in GABAergic activity within the basal ganglia and thalamus. Accompanying changes in GABA(B) receptor binding have...
8.
ONeill M, Murray T, Lakics V, Visanji N, Duty S
Curr Drug Targets CNS Neurol Disord
. 2003 May;
1(4):399-411.
PMID: 12769612
In the last five years there has been a rapid explosion of publications reporting that neuronal nicotinic acetylcholine receptors (nAChRs) play a role in neurodegenerative disorders. Furthermore, there is a...
9.
Messenger M, Dawson L, Duty S
Neuropharmacology
. 2002 Sep;
43(2):261-71.
PMID: 12213280
Metabotropic glutamate (mGlu) receptors in the basal ganglia motor loop may increase cell excitability (Group I) or modulate neurotransmitter release (Group I, II and III). Nigrostriatal tract degeneration in Parkinson's...
10.
Chadha A, Sur C, Atack J, Duty S
Br J Pharmacol
. 2000 Aug;
130(8):1927-32.
PMID: 10952684
This study examined whether activation of 5HT(1B) receptors in the rodent globus pallidus (GP) could reduce GABA release in vitro and reverse reserpine-induced akinesia in vivo. Microdissected slices of GP...